Terms: = Breast cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
4030 results:
1. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract] [Full Text] [Related]
3. Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative breast cancer Cells.
Dugina V; Vasileva M; Khromova N; Vinokurova S; Shagieva G; Mikheeva E; Galembikova A; Dunaev P; Kudlay D; Boichuk S; Kopnin P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674115
[TBL] [Abstract] [Full Text] [Related]
4. siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression.
Chaudhary P; Yadav K; Lee HJ; Kang KW; Mo J; Kim JA
Breast Cancer Res; 2024 Apr; 26(1):72. PubMed ID: 38664825
[TBL] [Abstract] [Full Text] [Related]
5. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract] [Full Text] [Related]
6. circ_JMJD1C expedites breast cancer progression by regulating miR-182-5p/JMJD1C/SOX4 axis.
Xu R; Lan H; Zhang L; Yang S; Mao Y; Che H
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):204-211. PubMed ID: 38650133
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Bagheri M; Mohamed GA; Mohamed Saleem MA; Ognjenovic NB; Lu H; Kolling FW; Wilkins OM; Das S; LaCroix IS; Nagaraj SH; Muller KE; Gerber SA; Miller TW; Pattabiraman DR
Cell Rep Med; 2024 Apr; 5(4):101504. PubMed ID: 38593809
[TBL] [Abstract] [Full Text] [Related]
8. BCAR4 facilitates trastuzumab resistance and emt in breast cancer via sponging miR-665 and interacting with YAP1.
Ye X; Liu Q; Qin X; Ma Y; Sheng Q; Wu X; Chen S; Huang L; Sun Y
FASEB J; 2024 Apr; 38(7):e23589. PubMed ID: 38572594
[TBL] [Abstract] [Full Text] [Related]
9. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J; Wilhelm C; Lebbé C; Elmallah M; Pamoukdjian F; Héraud A; Gapihan G; Walle AV; Tran VN; Hamdan D; Allayous C; Battistella M; Van Glabeke E; Lim KW; Leboeuf C; Roger S; Falgarone G; Phan AT; Bousquet G
Clin Transl Med; 2024 Mar; 14(3):e1632. PubMed ID: 38515278
[TBL] [Abstract] [Full Text] [Related]
10. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
[TBL] [Abstract] [Full Text] [Related]
11. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
12. Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance.
Palma FR; Coelho DR; Pulakanti K; Sakiyama MJ; Huang Y; Ogata FT; Danes JM; Meyer A; Furdui CM; Spitz DR; Gomes AP; Gantner BN; Rao S; Backman V; Bonini MG
Cell Rep; 2024 Mar; 43(3):113897. PubMed ID: 38493478
[TBL] [Abstract] [Full Text] [Related]
13. Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer.
Inayatullah M; Mahesh A; Turnbull AK; Dixon JM; Natrajan R; Tiwari VK
EMBO Mol Med; 2024 Apr; 16(4):823-853. PubMed ID: 38480932
[TBL] [Abstract] [Full Text] [Related]
14. Deubiquitinase BRCC3 promotes the migration, invasion and emt progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract] [Full Text] [Related]
15. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative breast cancer Metastases.
Ito K; Harada I; Martinez C; Sato K; Lee E; Port E; Byerly JH; Nayak A; Tripathi E; Zhu J; Irie HY
Cancer Res Commun; 2024 Mar; 4(3):946-957. PubMed ID: 38457262
[TBL] [Abstract] [Full Text] [Related]
16. SORBS1 inhibits epithelial to mesenchymal transition (emt) of breast cancer cells by regulating PI3K/AKT signaling and macrophage phenotypic polarization.
Feng K; Di Y; Han M; Yan W; Wang Y
Aging (Albany NY); 2024 Mar; 16(5):4789-4810. PubMed ID: 38451194
[TBL] [Abstract] [Full Text] [Related]
17. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
[TBL] [Abstract] [Full Text] [Related]
18. The role of telocytes and miR-21-5p in tumorigenicity and metastasis of breast cancer stem cells.
Babadag S; Altundag-Erdogan Ö; Akkaya-Ulum YZ; Çelebi-Saltik B
Mol Biol Rep; 2024 Mar; 51(1):395. PubMed ID: 38446251
[TBL] [Abstract] [Full Text] [Related]
19. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative breast cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract] [Full Text] [Related]
20. Simultaneous Visualization and Depletion of Peroxynitrite by a Simple Aggregation-Induced Emission Nanoprobe for Preventing breast cancer Metastasis after Surgery.
Zhang Z; Yu Y; Liu S; Li J; Zhao B; Wang F; Zhao Z; Ni Q; Liu F; Xue J
Anal Chem; 2024 Mar; 96(10):4180-4189. PubMed ID: 38436249
[TBL] [Abstract] [Full Text] [Related]
[Next]
